Notice on Convening the 2nd Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 2nd Extraordinary General Meeting in 2026
Filed with SSE · · 5 pages · Chinese
Release
Earlier from Sansure Biotech
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Joint Investment with a Related Party in Huasi Wuwei Technology (Shenzhen) Co., Ltd.
- Announcement on Joint Investment with a Related Party in Beijing Zheyuan Technology Co., Ltd.
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary
Later from Sansure Biotech
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Relevant Products
- Report for Q1 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Vesting Results in the 2nd Vesting Period of 2023 Restricted Stock Incentive Plan
Follow Sansure Biotech into a list and get an email when it puts out news.
Follow Sansure Biotech